These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 6351101)
1. Antiepileptic drug development program. Porter RJ Prog Clin Biol Res; 1983; 127():53-66. PubMed ID: 6351101 [TBL] [Abstract][Full Text] [Related]
2. The Antiepileptic Drug Development Program: an example of government-industry collaboration. White BG Prog Clin Biol Res; 1985; 197():83-93. PubMed ID: 4070302 [TBL] [Abstract][Full Text] [Related]
3. Advances in the clinical development of antiepileptic drugs. Porter RJ; Hessie BJ; Cereghino JJ; Gladding GD; Kupferberg HJ; Scoville B; White BG Fed Proc; 1985 Jul; 44(10):2645-9. PubMed ID: 3891417 [TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical industry screening for new antiepileptic drugs. Taylor CP; Marks JL Adv Neurol; 1998; 76():41-7. PubMed ID: 9408462 [TBL] [Abstract][Full Text] [Related]
6. Clinical development of drugs for epilepsy: a review of approaches in the United States and Europe. Porter RJ; Baulac M; Nohria V Epilepsy Res; 2010 May; 89(2-3):163-75. PubMed ID: 20347575 [TBL] [Abstract][Full Text] [Related]
7. Assessing pharmacokinetic and pharmacodynamic interactions in clinical trials of antiepileptic drugs. Reife RA Adv Neurol; 1998; 76():95-103. PubMed ID: 9408466 [TBL] [Abstract][Full Text] [Related]
8. Obtaining pediatric indications for new anti-epileptic drugs: how and when. Garofalo E Epilepsy Res; 2006 Jan; 68(1):38-42. PubMed ID: 16377135 [TBL] [Abstract][Full Text] [Related]
9. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
13. Carisbamate, a new carbamate for the treatment of epilepsy. Kulig K; Malawska B IDrugs; 2007 Oct; 10(10):720-7. PubMed ID: 17899491 [TBL] [Abstract][Full Text] [Related]
14. Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs. Gazzola DM; Balcer LJ; French JA Epilepsia; 2007 Jul; 48(7):1303-7. PubMed ID: 17521343 [TBL] [Abstract][Full Text] [Related]
15. Large clinical trials in epilepsy: funding by the NIH versus pharmaceutical industry. Privitera M Epilepsy Res; 2006 Jan; 68(1):52-6. PubMed ID: 16377139 [TBL] [Abstract][Full Text] [Related]
16. Role of the Institutional Review Board in clinical trials. Skolnick BE Epilepsy Res Suppl; 1993; 10():193-200. PubMed ID: 8251097 [No Abstract] [Full Text] [Related]
17. Preparing for an FDA audit. Barnes D Epilepsy Res Suppl; 1993; 10():245-50. PubMed ID: 8251103 [No Abstract] [Full Text] [Related]
18. Antiepileptic drug therapy in the United States: a review of clinical studies and unmet needs. Pellock JM Neurology; 1995 Mar; 45(3 Suppl 2):S17-24. PubMed ID: 7898741 [TBL] [Abstract][Full Text] [Related]
19. Aggravation of epilepsy by antiepileptic drugs. Sazgar M; Bourgeois BF Pediatr Neurol; 2005 Oct; 33(4):227-34. PubMed ID: 16194719 [TBL] [Abstract][Full Text] [Related]
20. [Anticonvulsive drug therapy. Historical and current aspects]. Bauer J; Elger CE Nervenarzt; 1995 Jun; 66(6):403-11. PubMed ID: 7543658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]